MINUTIA INC
Oakland, CA · Biotech · Private
Intracellular biosensing system for real-time monitoring of immune stress in transplanted stem cell-derived islets
minutia.co →- Grants
- $3.2M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Real-time intracellular monitoring of microRNAs in human stem cell-derived insulin producing organoids | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy | $870,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy | $870,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Monitoring and increasing resilience of stem cell derived pancreatic islet cell grafts | $324,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy | $870,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1333 | LEUKOSIGHT, INC. | — | — |
| 1334 | JT PHARMACEUTICALS, INC. | — | — |
| 1335 | YUMA THERAPEUTICS CORPORATION | — | — |
| 1336 | MINUTIA INC | — | — |
| 1337 | AVERY BIO CORPORATION | — | — |
| 1338 | SANERON CCEL THERAPEUTICS, INC. | — | — |
| 1339 | Cell-Free Bioinnovations Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Engineered Stem Cell Derived Grafts And Methods Of Use Thereofapplication
- Engineered Stem Cell Derived Grafts And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.